190 related articles for article (PubMed ID: 24412806)
1. How Parkinson's disease meets nucleolar stress.
Parlato R; Liss B
Biochim Biophys Acta; 2014 Jun; 1842(6):791-7. PubMed ID: 24412806
[TBL] [Abstract][Full Text] [Related]
2. [Parkinson's disease and nucleolar stress].
Zhou Q; Chen Y; Wei Q; Shang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Jun; 33(3):392-5. PubMed ID: 27264829
[TBL] [Abstract][Full Text] [Related]
3. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.
Rieker C; Engblom D; Kreiner G; Domanskyi A; Schober A; Stotz S; Neumann M; Yuan X; Grummt I; Schütz G; Parlato R
J Neurosci; 2011 Jan; 31(2):453-60. PubMed ID: 21228155
[TBL] [Abstract][Full Text] [Related]
4. Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models.
Evsyukov V; Domanskyi A; Bierhoff H; Gispert S; Mustafa R; Schlaudraff F; Liss B; Parlato R
Dis Model Mech; 2017 May; 10(5):633-643. PubMed ID: 28360124
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
[TBL] [Abstract][Full Text] [Related]
6. mTOR Signaling in Parkinson's Disease.
Lan AP; Chen J; Zhao Y; Chai Z; Hu Y
Neuromolecular Med; 2017 Mar; 19(1):1-10. PubMed ID: 27263112
[TBL] [Abstract][Full Text] [Related]
7. Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease.
Li DW; Li GR; Zhang BL; Feng JJ; Zhao H
Int J Mol Med; 2016 Feb; 37(2):429-35. PubMed ID: 26677001
[TBL] [Abstract][Full Text] [Related]
8. A neuroprotective phase precedes striatal degeneration upon nucleolar stress.
Kreiner G; Bierhoff H; Armentano M; Rodriguez-Parkitna J; Sowodniok K; Naranjo JR; Bonfanti L; Liss B; Schütz G; Grummt I; Parlato R
Cell Death Differ; 2013 Nov; 20(11):1455-64. PubMed ID: 23764776
[TBL] [Abstract][Full Text] [Related]
9. Synaptic dysfunction in Parkinson's disease.
Picconi B; Piccoli G; Calabresi P
Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
[TBL] [Abstract][Full Text] [Related]
10. Activation of an endogenous suicide response after perturbation of rRNA synthesis leads to neurodegeneration in mice.
Parlato R; Kreiner G; Erdmann G; Rieker C; Stotz S; Savenkova E; Berger S; Grummt I; Schütz G
J Neurosci; 2008 Nov; 28(48):12759-64. PubMed ID: 19036968
[TBL] [Abstract][Full Text] [Related]
11. Roles of the nucleolus in the CAG RNA-mediated toxicity.
Tsoi H; Chan HY
Biochim Biophys Acta; 2014 Jun; 1842(6):779-84. PubMed ID: 24269666
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress.
Russo A; Russo G
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085118
[TBL] [Abstract][Full Text] [Related]
13. The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy.
Woods SJ; Hannan KM; Pearson RB; Hannan RD
Biochim Biophys Acta; 2015 Jul; 1849(7):821-9. PubMed ID: 25464032
[TBL] [Abstract][Full Text] [Related]
14. Nucleolus and Nucleolar Stress: From Cell Fate Decision to Disease Development.
Hua L; Yan D; Wan C; Hu B
Cells; 2022 Sep; 11(19):. PubMed ID: 36230979
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the pathways that protect from IL-13-mediated potentiation of oxidative stress-induced dopaminergic nerve cell death.
Maher P; Conti B
Cytokine; 2018 Mar; 103():114-120. PubMed ID: 28969943
[TBL] [Abstract][Full Text] [Related]
16. PI3K/AKT signaling mediated by G protein‑coupled receptors is involved in neurodegenerative Parkinson's disease (Review).
Nakano N; Matsuda S; Ichimura M; Minami A; Ogino M; Murai T; Kitagishi Y
Int J Mol Med; 2017 Feb; 39(2):253-260. PubMed ID: 28000847
[TBL] [Abstract][Full Text] [Related]
17. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
Bisaglia M; Filograna R; Beltramini M; Bubacco L
Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson's Disease.
Prasad KN
Curr Aging Sci; 2017; 10(3):177-184. PubMed ID: 28042771
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's Disease.
Wang X; Li N; Xiong N; You Q; Li J; Yu J; Qing H; Wang T; Cordell HJ; Isacson O; Vance JM; Martin ER; Zhao Y; Cohen BM; Buttner EA; Lin Z
Mol Neurobiol; 2017 May; 54(4):2878-2888. PubMed ID: 27021023
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
Yang Y; Gehrke S; Haque ME; Imai Y; Kosek J; Yang L; Beal MF; Nishimura I; Wakamatsu K; Ito S; Takahashi R; Lu B
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13670-5. PubMed ID: 16155123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
